Novartis Investigative Site

Formosa, Formosa Province P3634XAR

0 studies enrolling now · 5 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia - Heterozygous, Heart Failure With Reduced Ejection Fraction, Heterozygous or Homozygous Familial Hypercholesterolemia, Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• Long-term Safety and Tolerability of Inclisiran in Participants With HeFH or HoFH Who Have Completed the Pediatric ORION-16, ORION-13, ORION-20, or ORION-19 Studies — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early